FORNARI, FRANCESCA
FORNARI, FRANCESCA
QUVI - DIPARTIMENTO DI SCIENZE PER LA QUALITA' DELLA VITA
Docenti di ruolo di IIa fascia
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma
2025 Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alimenti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C.
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
2025 Monti, E.; Vianello, C.; Leoni, I.; Galvani, G.; Lippolis, A.; D'Amico, F.; Roggiani, S.; Stefanelli, C.; Turroni, S.; Fornari, F.
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
2024 Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
2023 Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
2023 Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
2022 Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing?
2022 Gramantieri Laura; Fornari Francesca
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
2022 Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere
Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma
2022 Fornari Francesca; Gramantieri Laura
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
2021 Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers
2021 Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F.
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
2021 Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas
2021 Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L.
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2020 Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma
2020 Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; Perrucci A.; Astolfi A.; Piscaglia F.; Gramantieri L.
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
2020 Gramantieri L.; Pollutri D.; Gagliardi M.; Giovannini C.; Quarta S.; Ferracin M.; Casadei-Gardini A.; Callegari E.; De Carolis S.; Marinelli S.; Benevento F.; Vasuri F.; Ravaioli M.; Cescon M.; Piscaglia F.; Negrini M.; Bolondi L.; Fornari F.
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming
2020 Kowalik, Ma; Puliga, E; Cabras, L; Sulas, P; Petrelli, A; Perra, A; Ledda-Columbano, Gm; Morandi, A; Merlin, S; Orrù, C; Sanchez-Martin, C; Fornari, F; Gramantieri, L; Parri, M; Rasola, A; Bellomo, Se; Sebastian, C; Follenzi, A; Giordano, S; Columbano, A
Animal models of hepatocellular carcinoma prevention
2019 Shankaraiah R.C.; Gramantieri L.; Fornari F.; Sabbioni S.; Callegari E.; Negrini M.